Friday, September 18, 2020
wellness India Expo
Home Tags Biocon

Tag: Biocon

BioVoice eMag April 2017 Issue-11 Volume-1

BioVoice eMag April 2017 Issue-11 Volume-1: The ‘April 2017’ issue of BioVoice eMagazine includes the COVER STORY on Biorevolution 2.0: India’s quest to become a biotech...

USFDA accepts Mylan & Biocon’s proposed biosimilar Pegfilgrastim for review

The development marks the second successful biologics license application (BLA) for filing of the partnership in the United States of America...

India has 1022 biotech start-ups; $2.8 billion in biotech-led investments: ABLE’s...

The report compiled by the Association of Biotechnology Led Enterprises's in-house research team was first such study to map India’s biotech start-ups ecosystem...

Biocon wins INR 460 crore contract for Insulin from Malaysian govt

The company will supply rh-Insulin manufactured at its new facility in Malaysia to public sector hospitals and clinics through CCM Pharmaceuticals....

US-FDA accepts Mylan & Biocon’s joint application on biosimilar Trastuzumab

While the Biologics License Application (BLA) for MYL-1401O has been accepted by the United States FDA, if approved, it has the potential to be the first biosimilar Trastuzumab in the US....

Dr Kiran Shaw to debut at Serendipity Arts Festival 2016

As she debuts at the Art & Science Exhibition, Kiran M Shaw is one of the many patrons that have come on board.....

Delhi set to host ABLE’s BioEconomy Conclave 2016

The Association of Biotechnology Led Enterprises (ABLE) is organizing the BioEconomy India Conclave 2016 on November 29-30 at India Habitat Centre, Delhi....

Mylan & Biocon announce first joint USFDA submission for biosimilar, Trastuzumab

Besides being an important milestone of Biocon and Mylan's joint global biosimilars program, the first biosimilar trastuzumab if approved by the top regulator.....

Syngene registers Rs 319 crore as revenue in Q2

Syngene International, Biocon’s contract research arm has registered a 22 per cent increase in revenue......

Biocon’s net profit jumps to Rs 146.7 cr in 2nd quarter...

With consolidated net profit of Rs 146.7 crore, the biotechnology giant, Biocon has shown good performance for the second quarter of financial year 2016-17....